N/A N=10 KNA Proof-of-Concept
Adherence, Treatment · Retention · Cognitive Impairment, Mild
Primary: Ketogenic Adherence — 8 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=203 Potency and Precision Investigation
Depression, Anxiety
Primary: Working Alliance Inventory-Short Revised (WAI-SR), Total Scale — 3.63; 3.25; 3.95; 3.61 score on a scale
N/A N=126 Feasibility Studies of Personalized Closed Loop
Type 1 Diabetes
Primary: Number of Severe Hypoglycemic Event - Cohort A — 0 events
N/A N=72 Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
Skin Aging
Primary: Change From Baseline in Ra (a dermaTOP Parameter), of Test Product Treated Versus (vs.) Untreated Side at Day 29 — -1.90; -0.12 Micro meter (µm) — p=0.0638
Phase 2 N=5 Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in the Chronic Respiratory - Self Administered Individualized (CRQ-SAI) Dyspnea Domain Score at 12 Weeks — 2.00; -0.20 Score on a scale
N/A N=66 A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm
Skin Care
Primary: Change From Baseline in Transepidermal Water Loss (TEWL) Measurements on Day 29, Test Product Treated Versus (vs.) Untreated Sites on the Forearm — -0.59; 0.79 gram…
N/A N=114 A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain
Peripheral Neuropathies · Osteoarthritis
Primary: Patient's Change From Baseline of Pain Severity as Measured by the Weekly Means of the Daily Average Pain Scores (APS) During 4 Weeks of Treatment — 0.54; 0.95 score on…
N/A N=34 Weight Management Intervention in College: A Pilot Study
Obesity
Primary: Acceptability — 4.6; 4.2 score
N/A N=5 Validation of Point Partial User Needs With Partial Finger Amputees
Amputation; Traumatic, Hand
Primary: VAL-1: System Comfort Validation Test — 100 % of participants who Passed test
N/A N=127 Feasibility Study on the Model School Pediatric Health Initiative Pilot Project
School Board Health Centers
Primary: Number of Enrolled Participants Who Attended SBHC — 127; 252 participants
N/A N=47 Chronic Care Management/Patient Relationship Management Proof of Concept
Diabetes Mellitus
Primary: Patient Engagement — 68.14 text message response rate (percent)
Phase 2 N=13 Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
Early Alzheimer's Disease
Primary: Mean Percent Change in Apolipoprotein A-I (ApoA-I) in Cerebrospinal Fluid (CSF) — -8.4 percent change from screening visit — p=0.425
N/A N=21 Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device
Lower Extremity Lymphoedema · Leg Lymphoedema
Primary: Limb Volume (ml) — -197; -60; 45 ml
N/A N=20 Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
Diabetes Mellitus, Type 1
Primary: Safety, Low Blood Glucose Index (LBGI) — 0.64; 1.12 index score — p=0.003
N/A N=7 Validation of User Needs of the Point Digit With Partial Hand Amputees
Amputation; Traumatic, Hand
Primary: VAL-1: System Comfort Validation Test — 100 % of participants who Passed test
N/A N=46 Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)
Colorectal Cancer · Bladder Cancer · Ovarian Cancer
Primary: Enrollment Number — 25 Number of dyad participants
Phase 4 N=29 Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
Type 1 Diabetes
Primary: Change in A1C From Baseline to Week 15 — -1.7; -1.0 percent glycated hemoglobin
N/A N=40 Open Label Study Using OsteoProbe System
Adverse Effects in the Use of the OsteoProbe System
Primary: The Number of Participants With Reported Device Related Serious Adverse Events. — 0 Participants
N/A N=20 Outpatient Control-to-Range: System and Monitoring Testing
Type 1 Diabetes Mellitus
Primary: Percent Time of Active CTR — 98 percentage of time of active CTR
N/A N=11 To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees
Amputation; Traumatic, Hand
Primary: Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) — 90.3 score on a scale
Phase 2 N=10 Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
Huntington Disease
Primary: Ratio of Inorganic Phosphate (Pi) Over Phosphocreatine (PCr): Pi/PCr — 0.44; 0.43; 0.44; 0.42 ratio
N/A N=18 Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
Pregnant · Postpartum
Primary: Feasibility to Obtain HbA1c Through Remote Data Collection — 17; 16 Participants
N/A N=21 Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome
Tourette Syndrome · Chronic Tic Disorder
Primary: Change in Global Severity of Tics and Clinical Condition as Measured by YGTSS — 20.19; 25.82 score on a scale
N/A N=20 Feasibility of BabyGentleStick- Adult Pilot Study
Lack of Adverse Events · Reduced Pain Response
Primary: Number of Adverse Events — 0; 1 events
N/A N=13 To Assess the Utility of the Point Digit in a Clinical Take-home Study
Amputation; Traumatic, Hand
Primary: Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) — 74.6 scores on a scale
N/A N=420 A Multi-Center Trial of the ProLung Test™
Solitary Pulmonary Nodule · Multiple Pulmonary Nodules
Primary: Clinical Efficacy in the Risk Stratification of Patients With Indeterminate Lesions — 70.37; 46.97; 68.47; 49.21 percentage
N/A N=120 Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth
Dentin Sensitivity
Primary: Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Baseline (Day 0) — 2.43; 2.44; 2.44; 2.34 score on a scale
N/A N=24 An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD
Drug Abuse
Primary: Usability Questionnaire - Question 1. — 16; 7; 1 Participants
N/A N=732 Tampon Design Validation Study
Menstruation
Primary: The Percentage of Used Tampons That Have Elongated — 2; 75; 4; 48 tampons
N/A N=20 Proof-of-Concept Study of an Integrated Mobile and Social Network Weight Loss Intervention
Obesity
Primary: Mean Number of Uses of the Temptation Tracker — 9.5 uses of this mobile app feature